0000000001312396

AUTHOR

Hans Matter

showing 3 related works from this author

Resolving Binding Events on the Multifunctional Human Serum Albumin

2020

Abstract Physiological processes rely on initial recognition events between cellular components and other molecules or modalities. Biomolecules can have multiple sites or mode of interaction with other molecular entities, so that a resolution of the individual binding events in terms of spatial localization as well as association and dissociation kinetics is required for a meaningful description. Here we describe a trichromatic fluorescent binding‐ and displacement assay for simultaneous monitoring of three individual binding sites in the important transporter and binding protein human serum albumin. Independent investigations of binding events by X‐ray crystallography and time‐resolved dyn…

Boron Compounds540 Chemistry and allied sciencesalbumin bindingIbuprofenSerum Albumin HumanMolecular Dynamics SimulationCrystallography X-Ray01 natural sciencesBiochemistryFluorescenceDrug DiscoverymedicineHumansSpatial localizationmulticolor assayskinetics investigationsGeneral Pharmacology Toxicology and PharmaceuticsBinding sitePharmacologychemistry.chemical_classificationBinding SitesMolecular Structure010405 organic chemistryBinding proteinBiomoleculeCommunicationOrganic ChemistryLauric AcidsTransporterdrug interactionsHuman serum albuminFluorescenceCommunications0104 chemical sciences010404 medicinal & biomolecular chemistry4-Chloro-7-nitrobenzofurazanchemistry540 ChemieBiophysicsMolecular MedicineDissociation kineticsswitchSENSE technologyWarfarinmedicine.drugChemmedchem
researchProduct

Identification and Characterization of a Single High-Affinity Fatty Acid Binding Site in Human Serum Albumin.

2017

A single high-affinity fatty acid binding site in the important human transport protein serum albumin (HSA) is identified and characterized using an NBD (7-nitrobenz-2-oxa-1,3-diazol-4-yl)-C12 fatty acid. This ligand exhibits a 1:1 binding stoichiometry in its HSA complex with high site-specificity. The complex dissociation constant is determined by titration experiments as well as radioactive equilibrium dialysis. Competition experiments with the known HSA-binding drugs warfarin and ibuprofen confirm the new binding site to be different from Sudlow-sites I and II. These binding studies are extended to other albumin binders and fatty acid derivatives. Furthermore an X-ray crystal structure …

0301 basic medicineAzolesSerum albuminIbuprofenSerum Albumin HumanMolecular Dynamics Simulation010402 general chemistryCrystallography X-Ray01 natural sciencesCatalysis03 medical and health sciencesProtein DomainsFatty acid bindingmedicineFluorescence Resonance Energy TransferHumansBinding siteBovine serum albuminNitrobenzeneschemistry.chemical_classificationBinding SitesbiologyChemistry010405 organic chemistryFatty AcidsFatty acidGeneral ChemistryGeneral MedicineLigand (biochemistry)Human serum albumin0104 chemical sciencesbody regionsDissociation constant030104 developmental biologyBiochemistryembryonic structuresbiology.proteinWarfarinmedicine.drugProtein BindingAngewandte Chemie (International ed. in English)
researchProduct

CCDC 1917091: Experimental Crystal Structure Determination

2020

Related Article: Lea Wenskowsky, Michael Wagner, Johannes Reusch, Herman Schreuder, Hans Matter, Till Opatz, Stefan Matthias Petry|2020|ChemMedChem|15|738|doi:10.1002/cmdc.202000069

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters4-[2-(55-difluoro-1-methyl-5H-4lambda55lambda5-dipyrrolo[12-c:2'1'-f][132]diazaborinin-3-yl)ethenyl]-NN-dimethylanilineExperimental 3D Coordinates
researchProduct